for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Johnson & Johnson

JNJ

Latest Trade

163.72USD

Change

0.32(+0.20%)

Volume

4,304,467

Today's Range

162.96

 - 

164.06

52 Week Range

133.65

 - 

179.92

As of on the New York Stock Exchange ∙ Minimum 15 minute delay

Pricing

Previous Close
163.40
Open
163.06
Volume
4,304,467
3M AVG Volume
124.85
Today's High
164.06
Today's Low
162.96
52 Week High
179.92
52 Week Low
133.65
Shares Out (MIL)
2,632.48
Market Cap (MIL)
430,990.00
Forward P/E
16.72
Dividend (Yield %)
2.59

Next Event

Johnson & Johnson at EBD Group BIO-Europe (Virtual)

Latest Developments

More

U.S. CDC Says Delivered 501,613,665 Doses Of Covid-19 Vaccine As Of Oct 22

U.S. CDC Says Delivered 498,702,405 Doses Of Covid-19 Vaccine As Of Oct 21

Johnson & Johnson Covid-19 Vaccine Booster Shot Authorized For Emergency Use By U.S. FDA

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

About Johnson & Johnson

Johnson & Johnson is a holding company, which is engaged in the research and development, manufacture and sale of a range of products in the healthcare field. It operates through three segments: Consumer, Pharmaceutical and Medical Devices. Its primary focus is products related to human health and well-being. The Consumer segment includes a range of products used in the skin health/beauty, over-the-counter medicines, baby care, oral care, women’s health and wound care markets. The Pharmaceutical segment is focused on six immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism and pulmonary hypertension. The Medical Devices segment includes a range of products used in the interventional solutions, orthopedic, surgery, and vision fields.

Industry

Biotechnology & Drugs

Contact Info

One Johnson & Johnson Plz

NEW BRUNSWICK, NJ

08933

United States

+1.732.5242455

https://www.jnj.com/

Executive Leadership

Alex Gorsky

Chairman of the Board, Chief Executive Officer

Paulus A. Stoffels

Vice Chairman- Executive Committee, Chief Scientific Officer

Joaquin Boix Duato

Vice Chairman - Executive Committee

Joseph J. Wolk

Chief Financial Officer, Executive Vice President

Peter M. Fasolo

Chief Human Resource Officer, Executive Vice President

Key Stats

2.05 mean rating - 19 analysts
Sell
Hold
Buy
Revenue (MM, USD)

2018

81.6K

2019

82.1K

2020

82.6K

2021(E)

94.3K
EPS (USD)

2018

8.180

2019

8.680

2020

8.030

2021(E)

9.793
Price To Earnings (TTM)
24.47
Price To Sales (TTM)
4.71
Price To Book (MRQ)
--
Price To Cash Flow (TTM)
21.67
Total Debt To Equity (MRQ)
--
LT Debt To Equity (MRQ)
--
Return on Investment (TTM)
--
Return on Equity (TTM)
--

Latest News

Latest News

Walmart, Walgreens U.S. stores roll out Moderna, J&J COVID-19 booster shots

Walgreens Boots Alliance Inc and Walmart Inc said on Friday their U.S. pharmacies started administering COVID-19 booster shots from Moderna Inc and Johnson & Johnson, in addition to previously authorized Pfizer-BioNTech booster.

CDC director: U.S. may update definition of full vaccination for COVID-19

Biden administration officials urged eligible Americans on Friday to get booster shots of a COVID-19 vaccine and the Centers for Disease Control and Prevention head said it may update its definition of what constitutes full vaccination.

Walgreens to administer Moderna, J&J COVID-19 booster shots at U.S. stores

Walgreens Boots Alliance Inc said on Friday customers can start receiving booster COVID-19 shots from Moderna Inc and Johnson & Johnson at its U.S. stores.

U.S. CDC signs off on Moderna, J&J COVID-19 vaccine boosters, mix-and-match shots

The U.S. Centers for Disease Control and Prevention (CDC) on Thursday recommended the COVID-19 vaccine boosters for recipients of the Moderna Inc and Johnson & Johnson shots, and said Americans can choose a different shot from their original inoculation as a booster.

BRIEF-U.S. CDC Advisers Vote In Favor of Moderna, J&J Covid-19 Vaccine Boosters

* U.S. CDC ADVISERS VOTE TO RECOMMEND MODERNA COVID-19 VACCINE BOOSTER FOR OLDER ADULTS, SOME HIGH-RISK INDIVIDUALS

U.S. CDC advisers weigh Moderna, J&J COVID-19 vaccine boosters, mix-and-match shots

A panel of advisers to the U.S. Centers for Disease Control and Prevention (CDC) on Thursday are considering several recommendations for rollout of COVID-19 vaccine boosters from Moderna Inc and Johnson & Johnson , expected to pave the way for additional shots for millions...

Israel to readmit COVID-vaccinated foreign tourists next month

(Corrects day of week in final paragraph to Wednesday, not Tuesday)

U.S. FDA clears Moderna, J&J COVID-19 boosters, backs use of different vaccine for boost

The U.S. Food and Drug Administration on Wednesday authorized booster doses of the COVID-19 vaccines from Moderna Inc and Johnson & Johnson, and said Americans can choose a different shot from their original inoculation as a booster.

U.S. FDA clears Moderna and J&J boosters, backs 'mix-and-match' strategy

The U.S. Food and Drug Administration on Wednesday authorized booster doses of the COVID-19 vaccines from Moderna Inc and Johnson & Johnson, and said Americans can choose a different shot than their original inoculation as a booster.

J&J keeps vaccine sales outlook unchanged after third-quarter miss

Johnson & Johnson on Tuesday reported lower-than- expected quarterly revenue after sales of its COVID-19 vaccine missed Wall Street estimates following a string of production setbacks.

US STOCKS SNAPSHOT-Wall St opens higher as earnings whip up risk appetite

U.S. stock indexes opened higher on Tuesday as upbeat quarterly reports from Johnson & Johnson and Travelers fired up risk appetite, after big banks kicked off the third-quarter earnings season on a positive note last week.

Johnson & Johnson maintains 2021 sales forecast for COVID-19 vaccine

Johnson & Johnson on Tuesday maintained its 2021 sales forecast for its COVID-19 vaccine at $2.5 billion and reported $502 million in sales of the single-dose shot in the third quarter. (Reporting by Manas Mishra in Bengaluru; Editing by Arun Koyyur)

Second J&J COVID-19 shot gets expert backing; FDA is looking at lowering age for Pfizer booster

Outside advisers to the U.S. Food and Drug Administration on Friday unanimously recommended the agency authorize a second shot of Johnson & Johnson's COVID-19 vaccine for all recipients of the one-dose inoculation.

U.S. FDA advisers vote in favor of booster for J&J COVID-19 vaccine

A panel of advisers to the U.S. Food and Drug Administration on Friday voted to recommend the authorization of a second dose of Johnson & Johnson's COVID-19 vaccine for people aged 18 and older at least two months after the first dose.

U.S. donates 17 million J&J doses to African Union

President Joe Biden told visiting Kenyan President Uhuru Kenyatta on Thursday that the United States will make a one-time donation of more than 17 million doses of the Johnson & Johnson vaccine to the African Union, the White House said.

J&J puts talc liabilities into bankruptcy

Johnson & Johnson on Thursday put into bankruptcy tens of thousands of legal claims alleging its Baby Powder and other talc-based products caused cancer, offloading the potential liabilities into a newly created subsidiary.

U.S. FDA advisers to vote on J&J vaccine booster

A panel of expert advisers to the U.S. health regulator is meeting on Friday to vote on the authorization of a booster shot of Johnson & Johnson's vaccine for people aged 18 and older, and the appropriate interval between the two doses.

J&J unit to manage talc claims files for bankruptcy protection

Johnson & Johnson said on Thursday its newly created unit that was established to hold and manage claims in the Baby Powder litigation, has filed for voluntary Chapter 11 bankruptcy protection. (Reporting by Amruta Khandekar; Editing by Maju Samuel)

France donates COVID-19 vaccine to Nigeria under COVAX scheme

Nigeria has received 501,600 doses of AstraZeneca's COVID-19 vaccine from the French government through the COVAX vaccine-sharing facility, a senior health official said on Thursday.

U.S. donates 17 million J&J doses to African Union

President Joe Biden told visiting Kenyan President Uhuru Kenyatta on Thursday that the United States will make a one-time donation of more than 17 million doses of the Johnson & Johnson vaccine to the African Union, the White House said.

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up